Danilo Fintini1*
Stefano Cianfarani2,3
Marta Cofini4†
Angela Andreoletti5†
Grazia Maria Ubertini1
Marco Cappa1
Melania Manco6*- 1Endocrinology Unit, Pediatric University Department, Bambino Gesù Children's Hospital, Rome, Italy
- 2Diabetes and Growth Disorders Unit, Dipartimento Pediatrico Universitario Ospedaliero Bambino Gesù Children's Hospital, Tor Vergata University, Rome, Italy
- 3Department of Women's and Children's Health, Karolinska Institute and University Hospital, Stockholm, Sweden
- 4Pediatric Clinic, Department of Surgical and Biomedical Sciences, University of Perugia, Perugia, Italy
- 5Pediatric Resident, Pediatric Clinic, University of Brescia, Brescia, Italy
- 6Research Area for Multifactorial Diseases, Bambino Gesù Children's Hospital, Rome, Italy
Excess adiposity in childhood may affect bone development, ultimately leading to bone frailty. Previous reports showing an increased rate of extremity fractures in children with obesity support this fear. On the other hand, there is also evidence suggesting that bone mineral content is higher in obese children than in normal weight peers. Both adipocytes and osteoblasts derive from multipotent mesenchymal stem cells (MSCs) and obesity drives the differentiation of MSCs toward adipocytes at the expense of osteoblast differentiation. Furthermore, adipocytes in bone marrow microenvironment release a number of pro-inflammatory and immunomodulatory molecules that up-regulate formation and activation of osteoclasts, thus favoring bone frailty. On the other hand, body adiposity represents a mechanical load, which is beneficial for bone accrual. In this frame, bone quality, and structure result from the balance of inflammatory and mechanical stimuli. Diet, physical activity and the hormonal milieu at puberty play a pivotal role on this balance. In this review, we will address the question whether the bone of obese children and adolescents is unhealthy in comparison with normal-weight peers and discuss mechanisms underlying the differences in bone quality and structure. We anticipate that many biases and confounders affect the clinical studies conducted so far and preclude us from achieving robust conclusions. Sample-size, lack of adequate controls, heterogeneity of study designs are the major drawbacks of the existing reports. Due to the increased body size of children with obesity, dual energy absorptiometry might overestimate bone mineral density in these individuals. Magnetic resonance imaging, peripheral quantitative CT (pQCT) scanning and high-resolution pQCT are promising techniques for the accurate estimate of bone mineral content in obese children. Moreover, no longitudinal study on the risk of incident osteoporosis in early adulthood of children and adolescents with obesity is available. Finally, we will address emerging dietary issues (i.e., the likely benefits for the bone health of polyunsaturated fatty acids and polyphenols) since an healthy diet (i.e., the Mediterranean diet) with balanced intake of certain nutrients associated with physical activity remain the cornerstones for achieving an adequate bone accrual in young individuals regardless of their adiposity degree.
Introduction
The public health burden of epidemic obesity in childhood has been increasing worldwide in the last three decades. When childhood obesity persists to adulthood, the risk of developing chronic diseases early in life is significantly increased (1). The last report of the World Health Organization (WHO) (2) shows that about 800,000 children in the WHO European Region suffer from severe obesity. According to Global Health Observatory data, 18% of youth aged 5–19 years-old worldwide were overweight or obese in 2016 (3, 4).
Growing evidence suggests that adiposity influences the child bone health. Previous studies found that children and adolescents with obesity have bone mineral content (BMC) (see glossary in Table 1) higher than normal-weight peers, indicating that the adipose tissue exerts a positive effect on bone structure (5–7). On the other hand, it has been reported an increased rate of extremity fractures in children with obesity, suggesting poorer bone quality (8, 9).
Table 1. Glossary of radiological bone parameters.
In young people with obesity, bone quality and structure result from the balanced effects of enhanced release of inflammatory and immunomodulatory cytokines (10, 11) and mechanical overload. Interestingly, both the adipose tissue and the bone are metabolically active organs, due to the constant production and release of molecules, cytokines and hormones. These molecules modulate in an endocrine and paracrine fashion a number of metabolic activities, whole body inflammatory status and energy metabolism (12, 13). Immune cells embedded in the adipose tissue contribute to the interplay between adipose tissue and bone, while mechanical stimuli exerted by the adipose tissue on the bone structure generate and/or amplify molecular signals. There is evidence suggesting a cross-talk between adipose tissue and bone, which regulate each other through feedback mechanisms (14).
In the present review, we will focus on the bone as an organ target of several signals from the adipose tissue, to answer the clinical question whether the bone of children and adolescents with obesity is unhealthy in comparison with normal-weight peers.
We will not address the role of the bone in the regulation of physiological functions that are pivotal in the obesity status such as glucose homeostasis, energy metabolism, and appetite control. This side of the cross-talk has been brilliantly discussed elsewhere (15–18). In brief, the bone is the fourth glucose consuming organ after muscle, liver and adipose tissue, but unlike these tissues, it consumes glucose preferentially trough the aerobic glycolysis. Osteocalcin (OCN), a molecule secreted specifically by osteoblasts, regulates glucose metabolism, and browning of the adipose tissue in intertwined concert with insulin and leptin. OCN influences glucose homeostasis, modulating both insulin sensitivity, and secretion. Other osteokines participate to the fine control of energy metabolism. For instance, lipocalin2 (LCN2) regulates appetite by acting on the melanocortin 4 receptor pathway. Sclerostin, bone morphogenetic proteins 6 (BMP6) and 7 (BMP7) modulate browning of the adipose tissue.
The review of available data on the influence of bone on adipose tissue homeostasis is outside the scope of this report. It is our aim (i) to provide insights into the actions that adiposity exerts on bone accrual in children with obesity; (ii) to critically discuss the published clinical investigations on bone health status of children and adolescents with obesity; (iii) to argue for the beneficial impact of a healthy lifestyle on the child bone status, focusing on emerging dietary issues related to the intake of certain micro and macronutrients that characterize, for instance, the Mediterranean Diet (MD), i.e., polyunsaturated fatty acids (PUFAs) and polyphenols.
Bone Development, Growth, and Puberty
The human skeleton undergoes several changes in size and shape during the different stages of life. Childhood and adolescence are characterized by rapid and significant longitudinal bone growth, areal bone expansion, and bone mineral accrual (19). Ninety percent of the peak bone mass is achieved in late teenage and the amount of bone mass reached by this age predicts BMD in adulthood (20, 21) (see glossary in Table 1).
Genetics accounts for 60–80% of difference in BMD during teenage (22). Hormonal milieu (23), individual and environmental modifiable factors (i.e., body weight, adiposity, diet and PA) influence BMD later in life (24). Bone mass is progressively accrued from birth through childhood. At puberty, there is an impressive acceleration of BMD accrual secondary to the influence of anabolic hormones such as growth hormone (GH), insulin like growth factor 1 (IGF-1) and insulin. GH and IGF-1 promote osteoblast differentiation, myogenesis and muscle development (25, 26). Insulin enhances osteoblast development, promotes OCN expression (27) and reduces bone reabsorption. At puberty, insulin secretion increases physiologically but the rise is higher in adolescents with obesity who develop mild to severe hyperinsulinemia. In a mice model of reduced hepatic insulin clearance, hyperinsulinemia has been associated with higher trabecular and cortical BMC, reduced bone formation but also decreased number of osteoclasts and markers of bone resorption. These findings suggest that hyperinsulinemia is associated with reduced bone turnover and, consequently, poor bone quality as shown schematically in Figure 1 (28).
Figure 1. Hyperinsulinemia is due to altered insulin secretion and clearance that are commonly associated with obesity. It acts on osteoblasts causing reduced bone formation but also decreased number of osteoclasts and markers of bone resorption. The final result is reduced bone turnover and hence poor bone quality. OCN, Osteocalcin.
During puberty, boys present increased bone width and size as compared with girls of the same age due to the action of testosterone on periosteal apposition (29). There is no significant difference between sexes in cortical thickness (30). Estrogens influence bone development in both sexes causing increased osteoblast differentiation and reduced osteoclast lifespan. Estrogen deficiency leads to osteoblast apoptosis, oxidative stress, increased osteoblast nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activity and high level of RANKL (receptor activator of NFκB ligand)/osteoprotegerin (OPG) ratio resulting in enhanced bone resorption (31). The maximal gain in bone mass is seen ~6 months after the adolescence growth spurt. Nevertheless, bone mass, and density continue to increase over years thereafter (29).
Among the modifiable factors of an individual affecting BMD, excess weight and adiposity are major players for bone accrual. Studies have reported a positive effect of fat mass on BMD in prepubertal children (6) and adults (32, 33). However, it seems that the hormonal milieu of puberty inverts the positive trend of the association between adiposity and BMD that, indeed, becomes negative after puberty (34–37).
Bone Marrow Development and Adipose Tissue
Bone marrow (BM) consists primarily of adipocytes (yellow marrow areas) or adipocytes and hematopoietic red blood cells (red marrow areas), that fill the cavities within the trabecular bone. Hematopoietic stem cells (HSCs) are hosted in BM microenvironments or niches where a variety of cells and molecules exert a fine-tuned regulation of their survival, self-renewal, differentiation and retention (38).
BM adipocytes arise from the differentiation of mesenchymal stem cell (MSCs). They belong to a heterogeneous population whose metabolism, lipid composition, secretory capacities and functional responses depend on their location within the BM. At birth, the BM is fully hematopoietic and contains no adipocytes. Soon after birth, adipocytes start to differentiate from MSCs. The hematopoietic BM converts gradually to fatty marrow. This conversion takes place initially from distal toward central skeleton and continues throughout aging (39). In long bones, tissue replacement starts in diaphysis. BMAT replacement occurs at the age of 10 years-old in the femur diaphysis, and at the age of 30 years in the distal metaphysis (40). By the end of adolescence, hematopoietic marrow remains in the proximal metaphysis of femur and humerus, spine, sternum, ribs, and skull. By early adulthood BM adipocytes that have been developing in the prenatal skeleton and increasing in number with aging, occupy up to 70% of the BM microenvironment (41).
Obesity influences bone microenvironment and health by different mechanisms that are concisely depicted in Figure 2. Firstly, obesity diverts MSC differentiation toward the adipocyte line at the expense of osteoblasts. This imbalance results in reduced bone formation and increased BMAT (10). Secondly, obesity that is often characterized by reduced levels of physical activity (PA), promotes osteoclast activity and bone resorption triggering the expression of receptor activator of nuclear factor κ B (RANK), favoring binding to its ligand RANKL, and conversely inhibiting OPG pathway (11). OPG is the decoy receptor that binds and thereby opposes RANKL (42). RANK is expressed on monocytes and macrophages. Binding of RANKL causes fusion of monocytes and macrophages and their differentiation into osteoclasts ultimately leading to increased bone resorption (43). Most inflammatory adipokines (i.e., tumor necrosis factor-α, TNF-alpha; interleukins (IL, IL1, IL6, IL17) upregulate RANK/RANKL expression (11). Thirdly, obese children have often a diet particularly rich in fats that may reduce intestinal calcium absorption causing decreased calcium availability for bone formation and boosting further inflammation (44–46). Fourthly, physical activity is a major mechanical stimulus for bone accretion and is often reduced in obese children.
Figure 2. Poor bone quality in young individuals with obesity may result from several mechanisms: increased rate of differentiation of Mesenchymal Stem Cells (MSCs) to adipocytes at the expense of osteoblasts; reduced physical activity that alter the balance between osteoblast and osteoclast activities through the RANK/RANKL and osteoprogerin (OPG) pathways; reduced calcium (Ca2+) availability from the diet owing to the high content of fats.
On the other hand, obesity, intended as excess adiposity in the visceral and subcutaneous compartments, increases the mechanical load to the bone and, by doing so, promotes accrual of the cortical bone that represents a kind of armor for the whole body. Cortical bone is ~80% of the total bone mass and is crucial in weight-bearing and physical performance (47). Computed tomography (CT) studies (48) demonstrated an inverse relationship between BMAT and BMC in the axial and appendicular skeleton of healthy adolescents and young adults regardless of sex. Such relationship was unrelated to whole body adiposity. The excess BMAT may reduce BMC by replacing bone cells with adipocytes thus altering the bone micro-environmental milieu and microstructure. Conversely, generalized adiposity with increased depots of subcutaneous and visceral tissue may favor bone accrual by exerting a mechanical stimulus on the bone.
Excess BMAT and Inflammatory Cytokines
In children and adolescents, the ectopic deposition of BMAT in skeleton sites where it is expected to develop later in life, might cause an imbalance between osteoblastic and osteoclastic activities, leading to reduced turnover, bone fragility (49) and early-onset osteoporosis. Indeed, higher fraction of BMAT was associated with lower BMD values (50). A magnetic resonance imagining (MRI) study of 185 healthy children (5–18 years old) with wide range of body mass index (BMI) found an inverse correlation between BMAT and right femoral cortical bone area after adjusting for weight, total body fat, subcutaneous adipose tissue, visceral adipose tissue, and skeletal muscle (51). However, a longitudinal study demonstrating early-onset osteoporosis in individuals with obesity is lacking.
Excess BMAT releases a number of pro-inflammatory molecules. Most of them trigger RANK pathway (11), up-regulate osteoclast formation and activation (11, 52) and exert paracrine effects that vary in the different skeletal compartments (i.e., trabecular vs. cortical) (48, 53, 54) and sites (i.e., weight-bearing vs. not-weight-bearing). The adipose tissue expresses many adipokines, i.e., leptin, adiponectin, IL6, IL10, monocyte chemotactic protein-1 (MCP-1), TNF-α, macrophage colony stimulating factor. The obesity status is also characterized by altered levels of molecules that either affect bone growth (GH, parathyroid hormone, angiotensin II, 5-hydroxy-tryptamine) or modulate signaling pathways within the bone and the muscle tissues (i.e., advanced glycation end-products, myostatin and irisin). The effects of these molecules on preferential differentiation of MSCs to adipocytes or osteoblasts and bone remodeling have been investigated in cellular and animal models. The results of these studies are not entirely consistent, due both to heterogeneity of experimental designs and complex nature of adipokine signaling. Pro-inflammatory adipokines down-regulate osteoblasts, osteocytes, and muscle cells and upregulate osteoclasts.
The effect of some adipokines is dose-dependent. At physiological concentrations leptin promotes the production of the osteoclastogenic inhibitor OPG by osteoblasts but at higher concentrations (i.e., 10-fold higher than normal) is associated with inhibition of OPG and production of RANKL by osteoblasts (55). Another peripheral mechanism of leptin action at physiological concentrations is the modulation of MSCs differentiation to osteoblasts and their bone mineralization. In a murine model of conditional regulated leptin receptor gene recombination, it was found that leptin helps maintain MSCs in an undifferentiated state and promotes mineralization of more differentiated osteoblasts (56). In a mouse model of high-fat diet, increased levels of circulating leptin were associated with reduced tibial trabecular thickness, volume, and density (57), whereas mice treated with a leptin antagonist showed increased lumbar trabecular thickness (58). In general, leptin deficiency in mice affect cortical bone leading to reduced thickness (59). Leptin deficient mice had high bone mass that was reverted by cerebral intraventricular injection of leptin with consequent loss of trabecular bone. In tail suspended rats, lower doses of leptin were protective of bone loss, while high doses caused increased bone resorption and reduced bone formation (60).
Finally, leptin acts through a central neuroendocrine pathway that seems to involve hypothalamus, brainstem, and raphe nuclei likely via serotoninergic neurons to negatively regulate bone mass (61).
Overall these findings indicate that the net in vivo effect of leptin on the human bone physiology results from the balance of very complex interactions (62).
In obese children, Dimitri et al. found a negative association between leptin and BMC (63) and between its unbound form and OPG (64, 65). Leptin concentrations were inversely related to radial cortical porosity, radial cortical pore diameters, and tibial trabecular thickness (66).
Evidence from experimental models on the effect of the major adipokines on bone health is reported in Table 2.
Table 2. Adipokines and adipose tissue derived molecules that affect bone health.
In addition, some inflammatory molecules that are not directly expressed by adipocytes but by the immune cells embedded within the BMAT are also able to divert MSCs toward adipocytes at expense of osteoblasts. This is the case of some members of the TNF-α superfamily such as TRAIL and LIGHT/TNFSF14. The former has pro-osteoclastogenic and osteoblastic pro-apoptotic effects, whereas the latter has a well-defined pro-osteoclastogenic effect in different models of bone disease. In a pilot investigation, Brunetti et al. found higher serum levels and monocyte expression of LIGHT in 10 children with obesity as compared to healthy controls. LIGHT serum levels were inversely correlated with the bone transmission time Z-score measured by quantitative ultrasounds (52).
Exercise and Mechanical Signals Are Anabolic to Skeletal Tissue
Sedentary lifestyle influences negatively bone health reducing mass accrual and promoting tissue absorption. MSCs and their lineage-differentiated progeny are mechano-sensitive. Exercise induces the transmission of mechanical signals across the plasma membrane of MSCs through cytoskeletal proteins and transmembrane-bound integrins into the nucleus. Mechanical stimuli activate signaling cascades and induce cytoskeletal adaptations that initiate osteogenic, chondrogenic and myogenic differentiation and inhibit adipocyte differentiation down-regulating the peroxisome proliferator-activated receptor gamma (PPARγ)-driven adipogenic pathways. Bed stay and bone disuse increase the expression of PPARγ in MSCs and RANKL in BM, which promote osteoclast mediated bone resorption. The effects of bone disuse are promptly reverted by PA and mechanical stimuli [recently revised in (90)].
In a meta-analysis of 27 studies investigating the effect of PA on bone development and accrual, Berhinger found that weight bearing and exercise promote BMC gain. This effect is more evident during pubertal growth than after puberty, suggesting that the skeleton is more responsive to PA during this age window. Nevertheless, they concluded that there is no apparent correlation between PA intensity and BMC (91).
It is reasonable that weight-bearing exercise, the cornerstone in treatment and prevention of adult osteoporosis, works also in children and adolescents with obesity to prevent fragility and to improve bone health. Intramuscular fat impairs muscle strength and PA counteracts the accumulation of fat in the muscle fibers. Therefore, PA produces a range of mechanical stimuli and soluble signals across the skeleton and musculature targeting cells, tissues and organs that result in increased lean muscle mass, BMC, turnover rate and reduced low-grade local and systemic inflammation. In the absence of mechanical load, osteoclast-mediated resorption is accelerated by the secretion of inflammatory adipokines released into BM, i.e., the transforming growth factor-β (TGFβ). High levels of inflammatory adipokines result in bone resorption that is not accompanied by bone formation. It is noteworthy that increased levels of TGFβ cause impaired calcium gradient across muscle fibers and ultimately affect bone-muscle crosstalk (90, 92).
PA stimulates muscle release of irisin, a hormone-like myokine. Once released into the circulation, irisin acts on white adipocytes to induce their browning response but it may be also beneficial for bone health. In mice, irisin produced during exercise had positive effects on cortical mineral density and geometry (93, 94). In 6–8 years-old children, Soininen et al. found a significant positive association between circulating irisin and BMD (95).
The adequate intake of calcium and vitamin D seems to play a key role in bone mass accrual at puberty enhancing the beneficial effects of exercise. A recent systematic review has shown an additive effect of calcium intake and PA on bone health in children with low dietary calcium intake. The effect was more evident when the supplementation was done in early puberty and in weight-bearing bones (96). Nevertheless, the available data are still inconclusive as based on small sample sizes, no randomized controlled trials and no longitudinal studies.
Techniques to Investigate Bone Density, Content, and Microstructure
Bone mineral accrual is estimated in clinical practice by Dual X-ray absorptiometry (DXA). DXA scan generates a 2-dimensional (2D) planar image and provides a measure of BMC (g) and areal-BMD (aBMD, g/cm2) (Table 1). Given a reference population, the DXA software generates an age and gender specific z-score (standard deviation score) (97). The technique is not free of limitations. Data produced by equipment of different brands (Hologic vs. Lunar) have their own software and reference population data which do not allow consistent comparisons. Reference standards need to be made in full awareness of sample size, gender, age, and ethnicity of the reference population (98). The most serious limitation of DXA is that it provides a 2D image of a 3D structure. Thus, aBMD overestimates true bone density (g/cm3) in taller children with larger bones while underestimating it in shorter children with smaller bones. Obese children are often taller and tend to have larger bones. In these children, the accuracy of DXA measurements is reduced and clinical interpretation biased (99, 100). Indeed, interpretation of DXA parameters of an obese child remains challenging. Bone density may be corrected for body size to overcome this limit, but a consensus on this procedure is yet to be reached (97, 98, 101–104). It is a matter of fact that obese children have lower BMC when it is corrected for body size (101, 102, 105). Current guidelines recommend the use of bone mineral apparent density (BMAD) (Table 1) for the assessment of lumbar bone density and height for age adjusted Z-score for the assessment of total body less head (TBLH) bone density (106). The adjustment of BMC, bone area and aBMD for soft tissue (muscle vs. adipose tissue) may represent another option to test (102).
Progress in bone imaging has shifted attention to the bone microarchitecture as proxy of bone quality and health. Peripheral quantitative CT (pQCT) scanning and high-resolution pQCT (HRpQCT), with spatial resolution of 64 mm, allow measuring in vivo the volumetric parameters of trabecular and cortical compartments. They provide a sort of virtual “bone biopsy” that investigates bone microarchitecture. In long bones, pQCT reports global bone strength, expressed as thickness, periosteal and endosteal circumference and section modulus (102). The application of micro-fine element analysis (FEA), an engineering tool to derive bone mechanical properties as they relate to its microstructure, to HRpQCT images of ultradistal tibia and radius provides an estimate of bone strength relative to load and stiffness (107). Cross sectional area of lower limb and muscle area can be derived from this technique as indicators of body composition (102, 108) thus providing information on the “muscle-bone” unit.
MRI makes a 3D reliable reproduction of trabecular and cortical bone, appendicular and central skeleton in different anatomical planes, with the advantage of not exposing the child to ionizing radiations. However, its use is currently limited to research purposes (51, 109).
Both HRpQCT and MRI techniques may be particularly useful for assessing bone quality during puberty when bone microarchitecture undergoes important changes.
Quantitative ultrasound (QUS) is a radiation-free technique that informs about the mineral status measuring the amplitude-dependent speed of sound (Ad-SoS; m/sec), Broadband Ultrasound Attenuation (BUA; dB/MHz), and the bone transmission time (BTT) in tibia and radius. Unfortunately, there are no reference values for pediatric population and for different ethnicities (110). The International Society for Clinical Densitometry recommends its use for osteoporosis management in adults (111).
Strength and limitations of the imaging techniques are summarized in Table 3.
Table 3. Strengths and limitations of the imaging techniques.
Risk of Extremity Fractures in Obese Children
Extremity fractures are very frequent events in children and adolescents regardless of their body weight (112) with incidence peaking between ages 11–14 years in boys and 8–11 years in girls (113). There are raising concerns about a negative impact of fatness on bone mass since children with obesity are overrepresented in fracture groups (114–120), especially fractures of upper and lower extremities (118, 119, 121). A systematic review of 6 articles (N = 4,594 children; 867 with obesity and 3,727 normal-weight children) concluded that children with obesity have 25% higher risk of extremity fractures than normal-weight peers and also higher mortality rate (4.7 vs. 2.8%, respectively). As the authors acknowledged, confounders (ages, different mechanisms of injury, sample size, comorbidities) were not considered in the analysis that included exclusively retrospective studies of children involved in traumatic injuries (121). Nonetheless, a population-based study of 913,178 children aged 2–19 years-old confirmed the increased risk. The study, which did not provide information on mortality and therefore was not included in the former systematic review, found increased odds ratio of lower limb fractures in children with obesity. The risk increased with body weight. Children with extreme obesity had around 50% increased risk of foot, ankle, knee and leg fractures (9).
On the other hand, the increased risk of fractures might be due to weight-related clumsiness, postural instability and impaired gait that make children with obesity prone to fall and experience fractures (122–126).
BMC and BMD in Children With Obesity
There are inconsistencies between studies that investigated BMC/BMD and their relationship with fat mass and those investigating bone fragility and risk of fractures in children with obesity.
Both a history of prior fracture and overweight were predictors of future fracture in a cohort of 200 white girls (aged 3–15 years, half with recent forearm fracture and half age-matched with no history of bone fractures) followed up for 4 years. More than one third of girls with history of fracture had reduced lumbar BMD. An unexpected proportion of them was overweight (105). Likewise, in boys aged 3–19 years-old, excessive weight was a risk factor for distal forearm fractures. Low BMC, aBMD, BMAD and high fat mass were associated with increased risk of distal forearm fracture in boys. More than one third of the cases had reduced lumbar density and BMAD at radius, hip, and spine (117).
The same research group confirmed results in a different sample of 90 children with history of at least two forearm fractures in life. Children were scanned at different bone sites. Regions of interest were ultradistal radius, one-third radius, neck of femur, hip trochanter, lumbar, and total body. Early age of first fracture and overweight (33.3 vs. 15.5%) were both associated with enhanced risk of repeated fractures. As the number of fracture episodes increased, both BMC and BMD z-scores decreased, in particular at the ultradistal radius. Overweight children had the lowest mean BMC Z score at the ultradistal radius [−0.66 (1.22)] that was inversely associated with BMI z-score (115).
In the 8,348 young (8–18 years-old) participants to the US National Health and Nutrition Examination Survey (NHANES), BMD was adjusted for lean body mass, fat mass, ethnicity, age and gender. After adjustment for total body fat mass and percent body fat, children with obesity showed reduced whole body aBMD and lumbar spine aBMD, supporting the notion that people with obesity experience a real reduction of the bone mineral mass. In the study, pelvic aBMD was apparently not influenced by adiposity (127). These findings support an association between body weight or BMI and impaired BMC, at least at certain sites, with consequent increased risk of extremity fractures. Studies that focused on the association between adiposity, BMD and BMC, found that fat mass may have either a positive (5–7) or a neutral effect on bone (128, 129). A meta-analysis of 27 studies (N = 5,958 children) concluded (quality of evidence from moderate to high) that children with obesity have a significant higher bone mass than normal weight children as estimated by BMC, BMD, BMAD, and volumetric BMD (Table 1). Bone mass as estimated by whole body BMD was higher only in girls with obesity, but not in boys (7).
In a cohort of 3,082 children (mean age 9.9 years), Clark et al. found a positive association between whole body fat mass and TBLH bone area regardless of lean mass. In boys and prepubertal girls, fat mass predicted bone size gain after 2 years of follow up, independently of other factors suggesting that adipose tissue promotes bone growth in pre-pubertal children (6).
Microarchitecture and Bone Strength by QCT in Children With Obesity
Likewise, the results from pQCT/HR-pQCT investigations in children with obesity are controversial. 3D-cortical and trabecular microstructure and biomechanics at load-bearing and no-load bearing sites were studied in obese and lean children. Cortical porosity and mean cortical pore diameter at the radius were reduced in the obese group. Children with obesity showed reduced tibial trabecular thickness, increased trabecular numbers at the distal tibia but no difference in biomechanical properties of the bone (66). In a previous study, Farr et al. demonstrated no differences in the cortical and trabecular bone microarchitecture of obese and lean subjects (130).
QCT provides also the bone strength index (BSI, mg/mm4) that is an estimate of strength in response to compression at the distal end of long bones and is calculated as the product of total cross-sectional area (ToA) per total volumetric density (ToD)2. Overweight children had higher BSI than normal weight children at the tibia. Bone strength did not adapt to fat mass but to lean mass, suggesting that the bone strength, despite being increased, was not adequate to the larger fat mass of children with obesity (131).
The effect of adiposity on bone microstructure and strength may vary upon site of depot, i.e., fat mass seems to favor bone strength in lower limbs but not in upper limbs. Ducher et al. reported decreased bone strength at the forearm due to a greater percentage of fat mass in proportion to muscle mass (132).
In a cohort of 135 girls and 123 boys (age 8 years-old), bone strength was measured in response to torsion at 11, 13, 15, and 17 years of age by DXA and pQCT. Girls with overweight at baseline had significantly greater bone strength than normal weight girls while boys with overweight at baseline had greater bone strength than normal-weight children only at tibia and femoral neck but not at radius. When strength was adjusted by biological age, it was reduced in both girls and boys with overweight in comparison with normal-weight peers. These differences were no longer present when adjusted for lean mass in girls suggesting that the association between adiposity and bone strength is gender-specific (133).
Weight Loss and Physical Activity
In adults, weight loss leads to the reduction of BMD and enhances the risk of fractures (134). The effect of weight loss on the adolescent's bone health is still matter of debate.
In 92 obese adolescents engaged in 12 months weight loss trial, whole-body and vertebral BMC did not change respect to baseline despite the weight loss. On the contrary, upper and lower limb-specific BMCs for height were reduced, while lumbar-specific BMC for height was increased as compared to controls who were 54 normal weight and 12 overweight age- and height-matched adolescents (135). Gajewska et al. evaluated BMD, BMC and circulating adipokines in 40 pre-pubertal obese children before and after 1 year of weight loss program. They observed a positive association between the amount of weight reduction and the increase of BMC and BMD as absolute values. When the BMD z-score was considered, they found a reduction in BMD z-score that was positively correlated with the BMI z-score, suggesting a deceleration in bone mass gain in parallel with the weight loss. BMD z-score reduction was associated with decreased levels of bone alkaline phosphatase, leptin and sclerostin that are all markers of bone accrual, while levels of adiponectin increased (37).
Aerobic and anaerobic PA favor loss of weight, visceral and subcutaneous adiposity, and ameliorates insulin sensitivity in subjects with obesity. The combination of aerobic and non-aerobic activity (resistance training) improved BMC. Children who underwent a resistance training program showed higher BMC than peers under aerobic training alone but no difference in BMD (136). Conversely, sedentary habits were associated with decreased BMC (137).
Combination of aerobic plus resistance trainings was associated with improvement in lean body mass, higher levels of adiponectin, and reduced circulating leptin and low grade of inflammation in children and adolescents with obesity (136).
In a recent study, Munoz-Hernandez et al. investigated the combined effects of the Mediterranean diet and PA in overweight/obese children aged 8–12 years old. While they found no evident effect of the diet on bone health, a moderate to vigorous intensity PA was associated with the increase of both BMC and BMD. In particular, there was an increase of 10 g in BMC for 1 h/day increase of PA and 48 min/day reduction of sedentary habits (138).
One of the mechanisms of PA related improvement of bone health (93, 139) is the enhanced release of irisin. In a small sample of healthy children (aged 7–13 years), with a comparable intensity level of PA, circulating levels of irisin were positively associated with bone mineral status, assessed by QUS (140). Irisin contributes to browning of the adipose tissue, and in turn brown adipose tissue (BAT) seems to have a positive effect on cortical bone area. Indeed, Ponrartana et al. found a significant association between BAT volume and cortical bone area at the midshaft of the femur in 40 children and adolescents (141).
The evaluation of the net effect of weight loss on BMC and/or BMD is not straightforward for several reasons. Studies are heterogeneous in inclusion criteria, design, techniques of bone assessment, and data interpretation. Obese children and adolescents are taller than normal-weight subjects and have advanced bone-age and higher lean mass for height. Therefore, it is not easy to identify the appropriate controls. Pubertal spurt and rate of growth are important confounders. Differences in diet habits, micro to macronutrients balance, and intake of micronutrients are also important confounders. In addition, a weight loss program is often part of a lifestyle intervention that includes PA. Vigorous PA influences bone health (142), especially during growth, contributing to the bone mass peak, femoral neck BMD, and bone strength (142–146). Finally, small-size samples are a limitation for all these studies (147–149).
Regular aerobic and resistance (weight-bearing exercise) PA must be encouraged in young people with obesity representing an effective strategy to sustain bone tissue while ameliorating metabolic obesity-related morbidities (162–164).
Emerging Dietary Issues: Polyunsaturated Fatty Acids and Polyphenols
Adequate and balanced dietary intake of micro and macronutrients contributes to bone health. Mediterannean diet ensures the beneficial intake of micro and macronutrients, including valuable lipids (165–172).
Children with obesity have a diet often poor in micronutrients (i.e., calcium, vitamin D etc.) and rich in saturated fatty acids (SFAs) that cause decreased calcium availability for bone formation and favor low-grade inflammation. Reduced levels of circulating 25-hydroxyvitamin D (25-OHD), which is pivotal for bone health and accrual, have been often reported in children with obesity as compared to normal weight peers. On purpose, we will not discuss this issue, which has been the focus of a number of recent excellent reviews (173–175). We will focus on the link between dietary fatty acids (FAs) and bone metabolism.
FAs provide an important energy source, participate in cell signaling cascades, and serve as essential mediators of inflammation. An adequate intake of FAs and the balance between pro-inflammatory and anti-inflammatory PUFAs is critical for the maintenance of cellular functions and tissue homeostasis. A diet rich in SFAs or with a high ratio of pro-inflammatory n-6 PUFAs (i.e., Arachidonic acid, ARA; and Linoleic acid, LA) to anti-inflammatory n-3 PUFAs (i.e., docosahexaenoic, DHA; and eicosapentaenoic, EPA) may lead to altered bone biology (176–186). The metabolism of osteoblasts relies on fatty acid β-oxidation for 40–80% (158) and osteoblasts express several intra- and extra-cellular FA receptors, including PPARs, G protein-coupled receptor 40/Free fatty acid receptor 1 (GPR40/FFAR1), GPR120, Toll-like receptor-4 (TLR4), cluster of differentiation 36/fatty acid translocase (CD36/FAT) and PUFA receptors, including GPR40 and GPR120, that all have an important effect on osteoblasts and bone (186). Inflammation is up-regulated by SFAs and n-6 PUFAs in osteoblasts, while mineralization and osteoblastogenesis are down-regulated. Excess of SFAs has lipotoxic effects on the osteoblasts, while n-3 PUFAs seem beneficial. The balance between n-6 and n-3 PUFAs appears to be a modulator of physiological osteoblastogenesis (150–152).
Likewise, osteoclasts express a number of FA receptors, such as GPR40, TLR4, CD36, PPARs and other scavenger receptors that are mainly involved in the transport and metabolism of cholesterol and estradiol into these cells. The role of SFAs and n-6 PUFAs in osteoclasts is unclear, and there is conflicting evidence as to whether they upregulate or downregulate osteoclastogenesis (161, 187). N-3 PUFAs showed inhibitory effects on osteoclast functions and were associated with increased BMD (155–159). As to the n-6 PUFA arachidonic acid, it was found to either up- or down-regulate osteclastogenesis (161, 187).
Molecular mechanisms exerted by FAs and PUFAs on osteoblasts and osteoclasts are reported in Table 4.
Table 4. Molecular mechanisms of FAs on osteoblasts and osteoclasts.
The MD is beneficial for bone accrual and health also because of the high content in polyphenols. Polyphenols are phytochemicals normally found in fruits, plants and vegetables. They are protective against a number of chronic diseases, including osteoporosis. In vitro and animal models demonstrate that polyphenols can safeguard bone integrity by decreasing oxidative stress and inflammation, and modulating osteoblastogenesis/osteoclastogenesis balance as reviewed elsewhere in a recent issue of this Journal (188). Evidence in human studies, however, have provided no robust evidence on the beneficial effects of dietary polyphenols on bone mineral accrual and bone turnover markers in healthy adults and in patients with bone diseases (189). Furthermore, no clinical trial has been run in children with obesity to determine the effect of polyphenols on BMD.
A cornerstone in the diet is the intake of extra-virgin olive oil whose polyphenols can stimulate the proliferation of osteoblasts, modify their antigen profile, and promote alkaline phosphatase synthesis. Twenty-four hour treatment with 10−6 M of extra-virgin olive oil phenolic compounds (e.g., caeic acid, ferulic acid, coumaric acid, apigenin, and luteolin) modified gene expression of growth and differentiation/maturation osteoblasts markers such as the transforming growth factor b1 (TGF-1), TGF-b receptor 1, 2 and 3, BMP2, BMP7, run-related transcription factor 2 (RUNX-2), alkaline phosphatase (ALP), OCN, osterix Collagen type I (COL-I) and OPG (190). The effect of some phenolic compounds in the extra-virgin olive oil may be dose-dependent becoming toxic for cells at high doses cells (191). Indeed, treatment of mesenchymal cells with hydroxytyrosol 100 mM down regulated the expression of osteoblast differentiation markers and inhibited osteoblastogenesis (192), while the same dose of apigenin inhibited osteoblast differentiation markers (COL-I production, ALP, and calcium deposits) in murine osteoblasts (193).
Green tea is also rich of polyphenols (namely the epigallocatechin gallate) that improved bone health in a murine model of HFD induced obesity by the suppression of bone cell activity (194, 195). Vester et al. demonstrated that stimulation of primary human osteoblasts with low doses of green tea extracts during oxidative stress over 21 days improved mineralization and had beneficial effect on extra-cellular matrix production with higher gene expression of OCN and COL-I during osteoblasts differentiation (196).
A more recent study on peripheral blood mononuclear cells (PBMCs) of children with obesity and normal weight peers found that polyphenol cherry extracts have a beneficial effect on in vitro osteoclastogenesis determining a dose-dependent reduction of the expression of osteoclast genes, such as calcitonin receptor, cathepsin K and RANK. Twenty-four treatment of PBMCs from obese patients with 100 μg/ml polyphenol extracts from three different cultivars of cherries resulted in the significant reduction of the expression of TNF-a, whereas RANKL levels and cell viability were unchanged. Therefore, sweet cherry extracts, rich in anthocyanins, especially cyanidin-3O-rutinoside, and chlorogenic acids inhibited osteoclastogenesis in vitro mostly through a reduction of pro-osteoclastogenic cytokines (197).
Conclusions
This review was narrative and highlighted the number of unsolved issues about the effect of excess adiposity on the developing bone. We believe that a systematic review was unfeasible owing to the small number of clinical studies available from the literature and, moreover, to their extreme heterogeneity in the design.
No in vivo study provided robust evidence that bone health is impaired in children with obesity enhancing the risk of extremity fractures. In these patients, fractures may occur more frequently due to clumsiness that enhances risk of falls and to excess weight that generates greater mechanical forces trough the extremity bones. On the other hand, some studies found increased bone mass in overweight children. However, technical issues, i.e., the lack of gold standard methodology to estimate BMC in these patients with increased body size, prevented us from suggesting conclusive results. Emerging imaging techniques will be likely helpful to solve the question of whether the bone health is impaired in relation to the increased size, greater fat and lean mass, taller height, and advanced bone age of the obese youth.
Experimental evidence in animal and cellular models demonstrates that replacement of BM by adipose tissue alters the bone microenvironment and promotes low-grade inflammation, which in turn result in reduced osteoblast and enhanced osteoclast activities. A rearrangement of the bone microarchitecture and a prevailing bone reabsorption seem to be the net results of these processes. Without any doubt, bone accrual in children with obesity is affected by different humoral stimuli, i.e., inflammatory cytokines, adipokines and myokines. Nevertheless, their bone is also subjected to a mechanical work-load that is beneficial for bone accrual and geometry. Finally, there are emerging dietary issues that strongly suggest that the adequate intake of some natural compounds is beneficial for bone health.
In conclusion, in answering the main question addressed in this review, i.e., whether the bone mineral content is higher in children with obesity as compared to normal-weight peers or the bone structure of these individuals is more fragile, larger population studies are needed that will consider not only fatness of participants but also their inflammatory status, lifestyle habits in terms of PA (weight-bearing vs. not wear-bearing), sedentary conducts and dietary intake of macro-and micronutrients.
Author Contributions
DF analysis and interpretation of evidence and revision for important intellectual content. AA and MCo pubmed search and drafting of the manuscript. GU pubmed search and revision of the draft for important intellectual content. SC and MCa revision of the draft for important intellectual content. MM conception and design of the manuscript, analysis, and interpretation of evidence, drafting of the manuscript, and revision for important intellectual content.
Funding
Funds for open access publication fee received from the bambino Gesù children's Hospital.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
We are indebted to prof. Fabio Romerio, Institute of Human Virology, University of Maryland for his careful revision of the manuscript.
Abbreviations
Ad-SoS, amplitude-dependent speed of sound; AGEs, advanced glycation end-products; ARA, arachidonic acid; BM, bone marrow; BMAD, bone mineral apparent density; BMAT, bone marrow adipose tissue; BMC, bone mineral content; BMD, bone mineral density; BMI, body mass index; BMP6, bone morphogenetic protein 6; BMP7, bone morphogenetic protein 7; BSI, bone strength index; BTT, bone transmission time; BUA, broadband ultrasound attenuation; CCR2, C-C Motif Chemokine Receptor 2; CD36, cluster of differentiation 36; CT, computed tomography; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; DXA, dual X-ray absorptiometry; FAs, fatty acids; FAT, fatty acid translocase; FEA, micro-fine element analysis; FFAR1, free fatty acid receptor 1; GH, growth hormone; GPR40, G protein-coupled receptor 40; GPR120, G protein-coupled receptor 120; HrpQCT, high resolution pQCT; HSCs, hematopoietic stem cells; IGF-1, insulin like growth factor 1; IL, interleukins; LA, Linoleic acid; LCN2, lipocalin2; MCP-1, monocyte chemotactic protein-1; MRI, magnetic resonance imagining; MSCs, mesenchymal stem cell; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; NHANES, National Health and Nutrition Examination Survey; OCN, Osteocalcin; OPG, osteoprotegerin; PA, physical activity; PPARγ, peroxisome proliferator-activated receptor gamma; pQCT, Peripheral quantitative CT; QUS, quantitative ultrasound; PUFAs, polyunsaturated fatty acids; RAGE, receptors for advanced glycation end-products; RANK, receptor activator of nuclear factor κ B; RANKL, receptor activator of NFκB ligand; SFAs, saturated fatty acids; TBLH, total body less head; TGFβ, transforming growth factor-β; TLR4, Toll-like receptor-4; TNF-alpha, tumor necrosis factor-α; WHO, World Health Organization.
References
1. Daniels SR. Complications of obesity in children and adolescents. Int J Obes. (2009) 33(Suppl 1):S60–5. doi: 10.1038/ijo.2009.20
2. WHO report. Mapping the Health System Response to Childhood Obesity in the WHO. European Region, An overview and country perspectives (2019).
3. World Humanitarian Data and Trends. United Nations Office for the Coordination of Humanitarian Affairs (OCHA). (2018).
4. Global Humanitarian Overview. United nations coordinated support to people affected by disaster and conflict. United Nations Office for the Coordination of Humanitarian Affairs (OCHA). (2019).
5. Leonard MB, Shults J, Wilson BA, Tershakovec AM, Zemel BS. Obesity during childhood and adolescence augments bone mass and bone dimensions. Am J Clin Nutrit. (2004) 80:514–23. doi: 10.1093/ajcn/80.2.514
6. Clark EM, Ness AR, Tobias JH. Adipose tissue stimulates bone growth in prepubertal children. J Clin Endocrinol Metabol. (2006) 91:2534–41. doi: 10.1210/jc.2006-0332
7. Van Leeuwen J, Koes BW, Paulis WD, van Middelkoop M. Differences in bone mineral density between normal-weight children and children with overweight and obesity: a systematic review and meta-analysis. Obesity Rev. (2017) 18:526–46. doi: 10.1111/obr.12515
8. Fornari ED, Suszter M, Roocroft J, Bastrom T, Edmonds EW, Schlechter J. Childhood obesity as a risk factor for lateral condyle fractures over supracondylar humerus fractures. Clin Orthopaed Related Res. (2013) 471:1193–8. doi: 10.1007/s11999-012-2566-2
9. Kessler J, Koebnick C, Smith N, Adams A. Childhood obesity is associated with increased risk of most lower extremity fractures. Clin Orthopaed Relat Res. (2013) 471:1199–207. doi: 10.1007/s11999-012-2621-z
10. Da Silva SV, Renovato-Martins M, Ribeiro-Pereira C, Citelli M, Barja-Fidalgo C. Obesity modifies bone marrow microenvironment and directs bone marrow mesenchymal cells to adipogenesis. Obesity. (2016) 24:2522–32. doi: 10.1002/oby.21660
11. Roy B, Curtis ME, Fears LS, Nahashon SN, Fentress HM. Molecular mechanisms of obesity-induced osteoporosis and muscle atrophy. Front Physiol. (2016) 7:439. doi: 10.3389/fphys.2016.00439
12. Lee W-C, Guntur AR, Long F, Rosen CJ. Energy metabolism of the osteoblast: implications for osteoporosis. Endocrine Rev. (2017) 38:255–66. doi: 10.1210/er.2017-00064
13. Guntur AR, Rosen CJ. Bone as an endocrine organ. Endocrine Practice. (2012) 18:758–62. doi: 10.4158/EP12141.RA
14. Monod J, Jacob F. Teleonomic mechanisms in cellular metabolism, growth, and differentiation. Cold Spring Harbor Symposia Quantit Biol. (1961) 26:389–401. doi: 10.1101/SQB.1961.026.01.048
15. Rendina-Ruedy E, Rosen CJ. Lipids in the bone marrow: an evolving perspective. Cell Metabol. (2019) 31:219–31. doi: 10.1016/j.cmet.2019.09.015
16. Dirckx N, Moorer MC, Clemens TL, Riddle RC. The role of osteoblasts in energy homeostasis. Nat Rev Endocrinol. (2019) 15:651–65. doi: 10.1038/s41574-019-0246-y
17. Moser SC, van der Eerden BCJ. Osteocalcin-A versatile bone-derived hormone. Front Endocrinol. (2018) 9:794. doi: 10.3389/fendo.2018.00794
18. Pauk M, Bordukalo-Niksic T, Brkljacic J, Paralkar VM, Brault AL, Dumic-Cule I, et al. A novel role of bone morphogenetic protein 6 (BMP6) in glucose homeostasis. Acta Diabetol. (2019) 56:365–71. doi: 10.1007/s00592-018-1265-1
19. Kindler JM, Lewis RD, Hamrick MW. Skeletal muscle and pediatric bone development. Curr Opin Endocrinol Diabetes Obesity. (2015) 22:467–74. doi: 10.1097/MED.0000000000000201
20. Theintz G, Buchs B, Rizzoli R, Slosman D, Clavien H, Sizonenko PC, et al. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metabol. (1992) 75:1060–5. doi: 10.1210/jcem.75.4.1400871
21. Mccormack SE, Cousminer DL, Chesi A, Mitchell JA, Roy SM, Kalkwarf HJ, et al. Association between linear growth and bone accrual in a diverse cohort of children and adolescents. JAMA Pediatr. (2017) 171:e171769. doi: 10.1001/jamapediatrics.2017.1769
22. Mitchell JA, Chesi A, Elci O, McCormack SE, Kalkwarf HJ, Lappe JM, et al. Genetics of bone mass in childhood and adolescence: effects of sex and maturation interactions. J Bone Mineral Res. (2015) 30:1676–83. doi: 10.1002/jbmr.2508
23. Vanderschueren D, Vandenput L, Boonen S. Reversing sex steroid deficiency and optimizing skeletal development in the adolescent with gonadal failure. Endocrine Dev. (2005) 8:150–65. doi: 10.1159/000084100
24. Mouratidou T, Vicente-Rodriguez G, Gracia-Marco L, Huybrechts I, Sioen I, Widhalm K, et al. Associations of dietary calcium, Vitamin D, milk intakes, and 25-hydroxyvitamin D with bone mass in spanish adolescents: the HELENA study. J Clin Densitometry. (2013) 16:110–7. doi: 10.1016/j.jocd.2012.07.008
25. Florini JR, Ewton DZ, Coolican SA. Growth hormone and the insulin-like growth factor system in myogenesis. Endocrine Rev. (1996) 17:481–517. doi: 10.1210/edrv-17-5-481
26. Tritos NA, and Klibanski A. Effects of growth hormone on bone. Prog Mol Biol Transl Sci. (2016) 138:193–211. doi: 10.1016/bs.pmbts.2015.10.008
27. Fulzele K, Riddle RC, digirolamo DJ, Cao X, Wan C, Chen D, et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell. (2010) 142:309–19. doi: 10.1016/j.cell.2010.06.002
28. Huang S, Kaw M, Harris MT, Ebraheim N, Mcinerney MF, Najjar S M, et al. Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1. Bone. (2010) 46:1138–45. doi: 10.1016/j.bone.2009.12.020
29. Weaver CM, Gordon CM, Janz KF, Kalkwarf HJ, Lappe JM, Lewis R, et al. The national osteoporosis foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations. Osteopor Int. (2016) 27:1281–386. doi: 10.1007/s00198-015-3440-3
30. Neu CM, Rauch F, Manz F, Schœnau E. Modeling of cross-sectional bone size, mass and geometry at the proximal radius: a study of normal bone development using peripheral quantitative computed tomography. Osteopor Int.(2001) 12:538–47. doi: 10.1007/s001980170074
31. Khosla S, Oursler MJ, Monroe DG. Estrogen and the skeleton. Trends Endocrinol Metabol. (2012) 23:576–81. doi: 10.1016/j.tem.2012.03.008
32. Felson DT, Zhang Y, Hannan MT, Anderson JJ. Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Mineral Res. (1993) 8:567–73. doi: 10.1002/jbmr.5650080507
33. Ribot C, Tremollieres F, Pouilles JM, Bonneu M, Germain F, Louvet JP. Obesity and postmenopausal bone loss: the influence of obesity on vertebral density and bone turnover in postmenopausal women. Bone. (1987) 8:327–31. doi: 10.1016/8756-3282(87)90062-7
34. Nagasaki K, Kikuchi T, Hiura M, Uchiyama M. Obese Japanese children have low bone mineral density after puberty. J Bone Mineral Metabol. (2004) 22:376–81. doi: 10.1007/s00774-004-0498-y
35. Campos RMS, de Mello MT, Tock L, da Silva PL, Corgosinho FC, Carnier J, et al. Interaction of bone mineral density, adipokines and hormones in obese adolescent girls submitted in an interdisciplinary therapy. J Pediatr Endocrinol Metabol. (2013) 26:663–8. doi: 10.1515/jpem-2012-0336
36. Gajewska J, Weker H, Ambroszkiewicz J, Szamotulska K, Chełchowska M, Franek E, et al. Alterations in markers of bone metabolism and adipokines following a 3-month lifestyle intervention induced weight loss in obese prepubertal children. Exp Clin Endocrinol Diabetes. (2013) 121:498–504. doi: 10.1055/s-0033-1347198
37. Gajewska J, Ambroszkiewicz J, Klemarczyk W, Chełchowska M, Weker H, Szamotulska K. The effect of weight loss on body composition, serum bone markers, and adipokines in prepubertal obese children after 1-year intervention. Endocrine Res. (2018) 43:80–9. doi: 10.1080/07435800.2017.1403444
38. Crane GM, Jeffery E, Morrison SJ. Adult haematopoietic stem cell niches. Nat Rev Immunol. (2017) 17:573–90. doi: 10.1038/nri.2017.53
39. Ricci C, Cova M, Kang YS, Yang A, Rahmouni A, Scott WW, et al. Normal age-related patterns of cellular and fatty bone marrow distribution in the axial skeleton: MR imaging study. Radiology. (1990) 177:83–8. doi: 10.1148/radiology.177.1.2399343
40. Moore SG, Dawson KL. Red and yellow marrow in the femur: age-related changes in appearance at MR imaging. Radiology. (1990) 175:219–23. doi: 10.1148/radiology.175.1.2315484
41. Cawthorn WP, Scheller EL. Editorial: bone marrow adipose tissue: formation, function, and impact on health and disease. Front Endocrinol. (2017) 8:112. doi: 10.3389/fendo.2017.00112
42. Riches PL, Mcrorie E, Fraser WD, Determann C, Hof R, Van't Ralston SH. Osteoporosis associated with neutralizing autoantibodies against osteoprotegerin. N Engl J Med. (2009) 361:1459–5. doi: 10.1056/NEJMoa0810925
43. Souza PPC, Lerner UH. The role of cytokines in inflammatory bone loss. Immunol Invest. (2013) 42:555–622. doi: 10.3109/08820139.2013.822766
44. Denke MA, Fox MM, Schulte MC. Short-term dietary calcium fortification increases fecal saturated fat content and reduces serum lipids in men. J Nutr. (1993) 123:1047–53.
45. Welberg JW, Monkelbaan JF, de Vries EG, Muskiet FA, Cats A, Oremus ET, et al. Effects of supplemental dietary calcium on quantitative and qualitative fecal fat excretion in man. Annals Nutrition Metabol. (1994) 38:185–91. doi: 10.1159/000177810
46. Shahkhalili Y, Murset C, Meirim I, Duruz E, Guinchard S, Cavadini C, et al. Calcium supplementation of chocolate: effect on cocoa butter digestibility and blood lipids in humans. Am J Clin Nutr. (2001) 73:246–52. doi: 10.1093/ajcn/73.2.246
47. Cardadeiro G, Baptista F, Rosati N, Zymbal V, Janz KF, Sardinha LB. Influence of physical activity and skeleton geometry on bone mass at the proximal femur in 10- to 12-year-old children–a longitudinal study. Osteoporosis Int. (2014) 25:2035–45. doi: 10.1007/s00198-014-2729-y
48. Farr JN, Dimitri P. The impact of fat and obesity on bone microarchitecture and strength in children. Calcified Tissue Int. (2017) 100:500–13. doi: 10.1007/s00223-016-0218-3
49. Cao JJ. Effects of obesity on bone metabolism. J Orthopaed Surg Res. (2011) 6:30. doi: 10.1186/1749-799X-6-30
50. Cordes C, Baum T, Dieckmeyer M, Ruschke S, Diefenbach MN, Hauner H, et al. MR-based assessment of bone marrow fat in osteoporosis, diabetes, and obesity. Front Endocrinol. (2016) 7:74. doi: 10.3389/fendo.2016.00074
51. Gao Y, Zong K, Gao Z, Rubin MR, Chen J, Heymsfield SB, et al. Magnetic resonance imaging-measured bone marrow adipose tissue area is inversely related to cortical bone area in children and adolescents aged 5-18 years. J Clin Densitometr. (2015) 18:203–8. doi: 10.1016/j.jocd.2015.03.002
52. Brunetti G, Papadia F, Tummolo A, Fischetto R, Nicastro F, Piacente L, et al. Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α. Osteopor Int. (2016) 27:2355–65. doi: 10.1007/s00198-016-3501-2
53. Sukumar D, Schlussel Y, Riedt CS, Gordon C, Stahl T, Shapses SA. Obesity alters cortical and trabecular bone density and geometry in women. Osteopor Int. (2011) 22:635–45. doi: 10.1007/s00198-010-1305-3
54. Ootsuka T, Nakanishi A, Tsukamoto I. Increase in osteoclastogenesis in an obese Otsuka Long-Evans Tokushima fatty rat model. Mol Med Rep. (2015) 12:3874–80. doi: 10.3892/mmr.2015.3811
55. Lamghari M, Tavares L, Camboa N, Barbosa MA. Leptin effect on RANKL and OPG expression in MC3T3-E1 osteoblasts. J Cell Biochem. (2006) 98:1123–9. doi: 10.1002/jcb.20853
56. Scheller EL, Song J, Dishowitz MI, Soki FN, Hankenson KD, Krebsbach PH. Leptin functions peripherally to regulate differentiation of mesenchymal progenitor cells. Stem Cells. (2010) 28:1071–80. doi: 10.1002/stem.432
57. Fujita Y, Watanabe K, Maki K. Serum leptin levels negatively correlate with trabecular bone mineral density in high-fat diet-induced obesity mice. J Musculoskelet Neuronal Int. (2012) 12:84–94.
58. Solomon G, Atkins A, Shahar R, Gertler A, Monsonego-Ornan E. Effect of peripherally administered leptin antagonist on whole body metabolism and bone microarchitecture and biomechanical properties in the mouse. Am J Physiol Endocrinol Metabol. (2014) 306:E14–27. doi: 10.1152/ajpendo.00155.2013
59. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. (2000) 100:197–207. doi: 10.1016/S0092-8674(00)81558-5
60. Martin A, David V, Malaval L, Lafage-Proust M-H, Vico L, Thomas T. Opposite effects of leptin on bone metabolism: a dose-dependent balance related to energy intake and insulin-like growth factor-I pathway. Endocrinology. (2007) 148:3419–25. doi: 10.1210/en.2006-1541
61. Idelevich A, Baron R. Brain to bone: what is the contribution of the brain to skeletal homeostasis? Bone. (2018) 115:31–42. doi: 10.1016/j.bone.2018.05.018
62. Reid IR, Baldock PA, Cornish J. Effects of leptin on the skeleton. Endocrine Rev. (2018) 39: 938–59. doi: 10.1210/er.2017-00226
63. Dimitri P. The impact of childhood obesity on skeletal health and development. J Obesity Metabolic Syndrome. (2019) 28:4–17. doi: 10.7570/jomes.2019.28.1.4
64. Dimitri P, Wales JK, Bishop N. Adipokines, bone-derived factors and bone turnover in obese children; evidence for altered fat-bone signalling resulting in reduced bone mass. Bone. (2011) 48:189–96. doi: 10.1016/j.bone.2010.09.034
65. Faienza MF, D'Amato G, Chiarito M, Colaianni G, Colucci S, Grano M, et al. Mechanisms involved in childhood obesity-related bone fragility. Front Endocrinol. (2019) 10:269. doi: 10.3389/fendo.2019.00269
66. Dimitri P, Jacques RM, Paggiosi M, King D, Walsh J, Taylor ZA, et al. Leptin may play a role in bone microstructural alterations in obese children. J Clin Endocrinol Metabol. (2015) 100:594–602. doi: 10.1210/jc.2014-3199
67. Wang Y, Zhang X, Shao J, Liu H, Liu X, Luo E. Adiponectin regulates BMSC osteogenic differentiation and osteogenesis through the Wnt/β-catenin pathway. Sci Rep. (2017) 7:3652. doi: 10.1038/s41598-017-03899-z
68. Oshima K, Nampei A, Matsuda M, Iwaki M, Fukuhara A, Hashimoto J, et al. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophy Res Commun. (2005) 331:520–6. doi: 10.1016/j.bbrc.2005.03.210
69. Okazaki K, Yamaguchi T, Tanaka K-I, Notsu M, Ogawa N, Yano S, et al. Advanced glycation end products (AGEs), but not high glucose, inhibit the osteoblastic differentiation of mouse stromal ST2 cells through the suppression of osterix expression, and inhibit cell growth and increasing cell apoptosis. Calcified Tissue Intl. (2012) 91:286–96. doi: 10.1007/s00223-012-9641-2
70. Tanaka K, Yamaguchi T, Kanazawa I, Sugimoto T. Effects of high glucose and advanced glycation end products on the expressions of sclerostin and RANKL as well as apoptosis in osteocyte-like MLO-Y4-A2 cells. Biochem Biophy Res Commun. (2015) 461:193–9. doi: 10.1016/j.bbrc.2015.02.091
71. Muruganandan S, Dranse HJ, Rourke JL, McMullen NM, Sinal CJ. Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis. Stem Cells (Dayton, Ohio). (2013) 31:2172–82. doi: 10.1002/stem.1450
72. Muruganandan S, Roman AA, Sinal CJ. Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells. J Bone Mineral Res: The Official J Am Soc Bone Mineral Res. (2010) 25:222–34. doi: 10.1359/jbmr.091106
73. Sims NA. Cell-specific paracrine actions of IL-6 family cytokines from bone, marrow and muscle that control bone formation and resorption. The Intl J Biochem Cell Biol. (2016) 79:14–23. doi: 10.1016/j.biocel.2016.08.003
74. Thomas T, Burguera B. Is leptin the link between fat and bone mass? J Bone Mineral Res: The Official J Am Soc Bone Mineral Res. (2002) 17:1563–9. doi: 10.1359/jbmr.2002.17.9.1563
75. Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G. The molecular clock mediates leptin-regulated bone formation. Cell. (2005) 122:803–15. doi: 10.1016/j.cell.2005.06.028
76. Boucher H, Vanneaux V, Domet T, Parouchev A, Larghero J. Circadian clock genes modulate human bone marrow mesenchymal stem cell differentiation, migration and cell cycle. PLoS One. (2016) 11:e0146674. doi: 10.1371/journal.pone.0146674
77. Costa D, Lazzarini E, Canciani B, Giuliani A, Spanò R, Marozzi K, et al. Altered bone development and turnover in transgenic mice over-expressing lipocalin-2 in bone. J Cellular Physiol. (2013) 228:2210–21. doi: 10.1002/jcp.24391
78. Capulli M, Ponzetti M, Maurizi A, Gemini-Piperni S, Berger T, Mak TW, et al. A complex role for lipocalin 2 in bone metabolism: global ablation in mice induces osteopenia caused by an altered energy metabolism. J Bone Mineral Res: The Official J Am Soc Bone Mineral Res. (2018) 33:1141–53. doi: 10.1002/jbmr.3406
79. Roy B. Biomolecular basis of the role of diabetes mellitus in osteoporosis and bone fractures. World J Diabetes. (2013) 4:101–13. doi: 10.4239/wjd.v4.i4.101
80. Kim MS, Day CJ, Selinger CI, Magno CL, Stephens SRJ, Morrison NA. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption. J Biol Chem. (2006) 281:1274–85. doi: 10.1074/jbc.M510156200
81. Lee K-S, Kim H-J, Li Q-L, Chi X-Z, Ueta C, Komori T, et al. Runx2 is a common target of transforming growth factor beta 1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Molecular and Cellular Biology. (2000) 20:8783–92. doi: 10.1128/MCB.20.23.8783-8792.2000
82. Margoni A, Fotis L, Papavassiliou AG. The transforming growth factor-beta/bone morphogenetic protein signalling pathway in adipogenesis. Intl J Biochem Cell Biol. (2012) 44:475–9. doi: 10.1016/j.biocel.2011.12.014
83. Dole NS, Mazur CM, Acevedo C, Lopez JP, Monteiro DA, Fowler TW, et al. Osteocyte-intrinsic TGF-β signaling regulates bone quality through perilacunar/canalicular remodeling. Cell Reports. (2017) 21:2585–96. doi: 10.1016/j.celrep.2017.10.115
84. Zhao B. Does TNF promote or restrain osteoclastogenesis and inflammatory bone resorption? Critical Rev Immunol. (2018) 38:253–61. doi: 10.1615/CritRevImmunol.2018025874
85. Osta B, Benedetti G, Miossec P. Classical and paradoxical effects of TNF-α on bone homeostasis. Front Immunol. (2014) 5:48. doi: 10.3389/fimmu.2014.00048
86. Karnes JM, Daffner SD, Watkins CM. Multiple roles of tumor necrosis factor-alpha in fracture healing. Bone. (2015) 78:87–93. doi: 10.1016/j.bone.2015.05.001
87. Glass GE, Chan JK, Freidin A, Feldmann M, Horwood NJ, Nanchahal J. TNF-alpha promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells. Proc Natl Acad Sci USA. (2011) 108:1585–90. doi: 10.1073/pnas.1018501108.
88. Sun M, Yang J, Wang J, Hao T, Jiang D, Bao G, Liu G. TNF-α is upregulated in T2DM patients with fracture and promotes the apoptosis of osteoblast cells in vitro in the presence of high glucose. Cytokine. (2016) 80:35–42. doi: 10.1016/j.cyto.2016.01.011
89. Tsiklauri L, Werner J, Kampschulte M, Frommer KW, Berninger L, Irrgang M, et al. Visfatin alters the cytokine and matrix-degrading enzyme profile during osteogenic and adipogenic MSC differentiation. Osteoarthritis and Cartilage. (2018) 26:1225–35. doi: 10.1016/j.joca.2018.06.001.
90. Pagnotti GM, Styner M, Uzer G, Patel VS, Wright LE, Ness KK, et al. Combating osteoporosis and obesity with exercise: leveraging cell mechanosensitivity. Nat Rev Endocrinol. (2019) 15:339–55. doi: 10.1038/s41574-019-0170-1
91. Behringer M, Gruetzner S, mccourt M, Mester J. Effects of weight-bearing activities on bone mineral content and density in children and adolescents: a meta-analysis. J Bone Mineral Res. (2014) 29:467–78. doi: 10.1002/jbmr.2036
92. Waning DL, Mohammad KS, Reiken S, Xie W, Andersson DC, John S, et al. Excess TGF-β mediates muscle weakness associated with bone metastases in mice. Nat Med. (2015) 21:1262–71. doi: 10.1038/nm.3961
93. Colaianni G, Cuscito C, Mongelli T, Pignataro P, Buccoliero C, Liu P, et al. The myokine irisin increases cortical bone mass. Proc Natl Acad Sci USA. (2015) 112:12157–62. doi: 10.1073/pnas.1516622112
94. Singhal V, Lawson EA, Ackerman KE, Fazeli PK, Clarke H, Lee H, et al. Irisin levels are lower in young amenorrheic athletes compared with eumenorrheic athletes and non-athletes and are associated with bone density and strength estimates. PLoS ONE. (2014) 9:e100218. doi: 10.1371/journal.pone.0100218
95. Soininen S, Sidoroff V, Lindi V, Mahonen A, Kröger L, Kröger H, et al. Body fat mass, lean body mass and associated biomarkers as determinants of bone mineral density in children 6-8years of age - The Physical Activity and Nutrition in Children (PANIC) study. Bone. (2018) 108:106–14. doi: 10.1016/j.bone.2018.01.003
96. Yang X, Zhai Y, Zhang J, Chen JY, Liu D. Combined effects of physical activity calcium on bone health in children adolescents: a systematic review of randomized controlled trials. World J Pediatr. (2020). doi: 10.1007/s12519-019-00330-7. [Epub ahead of print].
97. Crabtree NJ, Shaw NJ, Bishop NJ, Adams JE, Mughal MZ, Arundel P, et al. Amalgamated reference data for size-adjusted bone densitometry measurements in 3598 children and young adults-the alphabet study. J Bone Mineral Res. (2017) 32:172–80. doi: 10.1002/jbmr.2935
98. Kocks J, Ward K, Mughal Z, Moncayo R, Adams J, Högler W. Z-score comparability of bone mineral density reference databases for children. J Clin Endocrinol Metabol. (2010) 95:4652–9. doi: 10.1210/jc.2010-0677
99. Fewtrell MS. Bone densitometry in children assessed by dual x ray absorptiometry: Uses and pitfalls. Arch Dis Childhood. (2003) 88:795-8. doi: 10.1136/adc.88.9.795
100. Vandewalle S, Taes Y, Van Helvoirt M, Debode P, Herregods N, Ernst C, et al. Bone size and bone strength are increased in obese male adolescents. J Clin Endocrinol Metabol. (2013) 98:3019–28. doi: 10.1210/jc.2012-3914
101. Dimitri P, Bishop N, Walsh JS, Eastell R. Obesity is a risk factor for fracture in children but is protective against fracture in adults: a paradox. Bone. (2012) 50:457–66. doi: 10.1016/j.bone.2011.05.011
102. Kelley JC, Crabtree N, Zemel BS. Bone density in the obese child: clinical considerations and diagnostic challenges. Calcified Tissue Int. (2017) 100:514–27. doi: 10.1007/s00223-016-0233-4
103. Carter DR, Bouxsein ML, Marcus R. New approaches for interpreting projected bone densitometry data. J Bone Mineral Res. (1992) 7:137–45. doi: 10.1002/jbmr.5650070204
104. Kröger H, Kotaniemi A, Vainio P, Alhava E. Bone densitometry of the spine and femur in children by dual-energy x-ray absorptiometry. Bone Mineral. (1992) 17:75–85. doi: 10.1016/0169-6009(92)90712-M
105. Goulding A, Jones IE, Taylor RW, Manning PJ, Williams SM. More broken bones: a 4-year double cohort study of young girls with and without distal forearm fractures. J Bone Mineral Res: The Official J Am Soc Bone and Mineral Res. (2000) 15:2011–18. doi: 10.1359/jbmr.2000.15.10.2011
106. Zemel BS, Kalkwarf HJ, Gilsanz V, Lappe JM, Oberfield S, Shepherd JA, et al. Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study. J Clin Endocrinol Metabol. (2011) 96:3160–9. doi: 10.1210/jc.2011-1111
107. Kirmani S, Christen D, van Lenthe GH, Fischer PR, Bouxsein ML, Mccready LK, et al. Bone structure at the distal radius during adolescent growth. J Bone Mineral Res. (2009) 24:1033–42. doi: 10.1359/jbmr.081255
108. Stagi S, Cavalli L, Cavalli T, de Martino M, Brandi ML. Peripheral quantitative computed tomography (pqct) for the assessment of bone strength in most of bone affecting conditions in developmental age: a review. Italian J Pediatr. (2016) 42:88. doi: 10.1186/s13052-016-0297-9
109. Pezzuti IL, Kakehasi AM, Filgueiras MT, de Guimarães JA, de Lacerda IAC, Silva IN. Imaging methods for bone mass evaluation during childhood and adolescence: an update. J Pediatr Endocrinol Metabol. (2017) 30:485–97. doi: 10.1515/jpem-2016-0252
110. Rivas-Ruiz R, Méndez-Sánchez L, Castelán-Martínez OD, Clark P, Tamayo J, Talavera JO, et al. Comparison of international reference values for bone speed of sound in pediatric populations: meta-analysis. J Clin Densitometr. (2016) 19:316–25. doi: 10.1016/j.jocd.2015.04.005
111. Schousboe JT, Shepherd JA, Bilezikian JP, Baim S. Executive summary of the 2013 ISCD position development conference on bone densitometry. JCD. (2013) 16:455–67. doi: 10.1016/j.jocd.2013.08.004
112. Skaggs DL, Loro ML, Pitukcheewanont P, Tolo V, Gilsanz V. Increased body weight and decreased radial cross-sectional dimensions in girls with forearm fractures. J Bone Mineral Res. (2001) 16:1337–42. doi: 10.1359/jbmr.2001.16.7.1337
113. Khosla S, Melton LJ, Dekutoski MB, Achenbach SJ, Oberg AL, Riggs BL. Incidence of childhood distal forearm fractures over 30 years: a population-based study. JAMA. (2003) 290:1479–85. doi: 10.1001/jama.290.11.1479
114. Goulding A, Taylor RW, Jones IE, Mcauley KA, Manning PJ, Williams SM. Overweight and obese children have low bone mass and area for their weight. Int J Obesity Related Metabolic Disord. (2000) 24:627–32. doi: 10.1038/sj.ijo.0801207
115. Goulding A, Grant AM, Williams SM. Bone and body composition of children and adolescents with repeated forearm fractures. J Bone Mineral Res. (2005) 20:2090–6. doi: 10.1359/JBMR.050820
116. Goulding A, Cannan R, Williams SM, Gold EJ, Taylor RW, Lewis-Barned NJ. Bone mineral density in girls with forearm fractures. J Bone Mineral Res. (1998) 13:143–8. doi: 10.1359/jbmr.1998.13.1.143
117. Goulding A, Jones IE, Taylor RW, Williams SM, Manning PJ. Bone mineral density and body composition in boys with distal forearm fractures: a dual-energy x-ray absorptiometry study. J Pediatr. (2001) 139:509–15. doi: 10.1067/mpd.2001.116297
118. Pomerantz WJ, Timm NL, Gittelman MA. Injury patterns in obese versus nonobese children presenting to a pediatric emergency department. Pediatrics. (2010) 125:681–5. doi: 10.1542/peds.2009-2367
119. Backstrom IC, Maclennan PA, Sawyer JR, Creek AT, Rue LW, Gilbert SR. Pediatric obesity and traumatic lower-extremity long-bone fracture outcomes. J Trauma Acute Care Surgery. (2012) 73:966–71. doi: 10.1097/TA.0b013e31825a78fa
120. Manias K, Mccabe D, Bishop N. Fractures and recurrent fractures in children; varying effects of environmental factors as well as bone size and mass. Bone. (2006) 39:652–7. doi: 10.1016/j.bone.2006.03.018
121. Kim SJ, Ahn J, Kim HK, Kim JH. Obese children experience more extremity fractures than nonobese children and are significantly more likely to die from traumatic injuries. Acta Paediatr. (2016) 105:1152–7. doi: 10.1111/apa.13343
122. Adams AL, Kessler JI, Deramerian K, Smith N, Black MH, Porter AH, et al. Associations between childhood obesity and upper and lower extremity injuries. Injury Prevent J Int Soc Child Adolescent Injury Prevent. (2013) 19:191–7. doi: 10.1136/injuryprev-2012-040341
123. Paulis WD, Silva S, Koes BW, van Middelkoop M. Overweight and obesity are associated with musculoskeletal complaints as early as childhood: a systematic review. Obesity Rev. (2014) 15:52–67. doi: 10.1111/obr.12067
124. Wearing SC, Hennig EM, Byrne NM, Steele JR, Hills AP. The impact of childhood obesity on musculoskeletal form. Obesity Rev. (2006) 7:209–18. doi: 10.1111/j.1467-789X.2006.00216.x
125. Colné P, Frelut ML, Pérès G, Thoumie P. Postural control in obese adolescents assessed by limits of stability and gait initiation. Gait Posture. (2008) 28:164–9. doi: 10.1016/j.gaitpost.2007.11.006
126. Deforche BI, Hills AP, Worringham CJ, Davies PSW, Murphy AJ, Bouckaert JJ, et al. Balance and postural skills in normal-weight and overweight prepubertal boys. Int J Pediatr Obesity. (2009) 4:175–82. doi: 10.1080/17477160802468470
127. Gállego Suárez C, Singer BH, Gebremariam A, Lee JM, Singer K. The relationship between adiposity bone density in U.S. children and adolescents. PLoS ONE. (2017) 12:e0181587. doi: 10.1371/journal.pone.0181587
128. Manzoni P, Brambilla P, Pietrobelli A, Beccaria L, Bianchessi A, Mora S, et al. Influence of body composition on bone mineral content in children and adolescents. Am J Clin Nutrition. (1996) 64:603–7. doi: 10.1093/ajcn/64.4.603
129. Petit MA, Beck TJ, Shults J, Zemel BS, Foster BJ, Leonard MB. Proximal femur bone geometry is appropriately adapted to lean mass in overweight children and adolescents. Bone. (2005) 36:568–76. doi: 10.1016/j.bone.2004.12.003
130. Farr JN, Amin S, lebrasseur NK, Atkinson EJ, Achenbach SJ, McCready L K, et al. Body Composition during childhood and adolescence: relations to bone strength and microstructure. J Clin Endocrinol Metabol. (2014) 99:4641–8. doi: 10.1210/jc.2014-1113
131. Wetzsteon RJ, Petit MA, Macdonald HM, Hughes JM, Beck TJ, McKay HA. Bone structure and volumetric BMD in overweight children: a longitudinal study. J Bone Mineral Res. (2008) 23:1946–53. doi: 10.1359/jbmr.080810
132. Ducher G, Bass SL, Naughton GA, Eser P, Telford RD, Daly RM. Overweight children have a greater proportion of fat mass relative to muscle mass in the upper limbs than in the lower limbs: implications for bone strength at the distal forearm. Am J Clin Nutrition. (2009) 90:1104–11. doi: 10.3945/ajcn.2009.28025
133. Glass NA, Torner JC, Letuchy EM, Burns TL, Janz KF, Eichenberger Gilmore JM, et al. The relationship between greater prepubertal adiposity, subsequent age of maturation, and bone strength during adolescence. J Bone Mineral Res. (2016) 31:1455–65. doi: 10.1002/jbmr.2809
134. Shapses SA, Sukumar D. Bone metabolism in obesity and weight loss. Annual Rev Nutrition. (2012) 32:287–309. doi: 10.1146/annurev.nutr.012809.104655
135. Stettler N, Berkowtiz RI, Cronquist JL, Shults J, Wadden TA, Zemel BS, et al. Observational study of bone accretion during successful weight loss in obese adolescents. Obesity. (2008) 16:96–101. doi: 10.1038/oby.2007.17
136. Campos RMS, de Mello MT, Tock L, Silva PL, Masquio DCL, de Piano A, et al. Aerobic plus resistance training improves bone metabolism and inflammation in adolescents who are obese. J Strength Conditioning Res. (2014) 28:758–66. doi: 10.1519/JSC.0b013e3182a996df
137. Lanigan J. Prevention of overweight and obesity in early life. Proc Nutrition Soc. (2018) 77:247–56. doi: 10.1017/S0029665118000411
138. Muñoz-Hernandez V, Arenaza L, Gracia-Marco L, Medrano M, Merchan Ramirez E, Martinez Avila WD, et al. Influence of physical activity on bone mineral content and density in overweight and obese children with low adherence to the mediterranean dietary pattern. Nutrients. (2018) 10:1075. doi: 10.3390/nu10081075
139. Colaianni G, Cinti S, Colucci S, Grano M. Irisin and musculoskeletal health. Annals N York Acad Sci. (2017) 1402:5–9. doi: 10.1111/nyas.13345
140. Colaianni G, Faienza MF, Sanesi L, Brunetti G, Pignataro P, Lippo L, et al. Irisin serum levels are positively correlated with bone mineral status in a population of healthy children. Pediatr Res. (2019) 85:484–8. doi: 10.1038/s41390-019-0278-y
141. Ponrartana S, Aggabao PC, Hu HH, Aldrovandi GM, Wren TA, Gilsanz V. Brown adipose tissue and its relationship to bone structure in pediatric patients. J Clin Endocrinol Metab. (2012) 97:2693–8. doi: 10.1210/jc.2012-1589
142. Gabel L, Macdonald HM, Nettlefold L, McKay HA. Physical activity, sedentary time, and bone strength from childhood to early adulthood: a mixed longitudinal HR-pqct study. J Bone Mineral Res: The Official J Am Soc Bone Mineral Res. (2017) 32:1525–36. doi: 10.1002/jbmr.3115
143. Davies JH, Evans BAJ, Gregory JW. Bone mass acquisition in healthy children. Arch Dis Childhood. (2005) 90:373–8. doi: 10.1136/adc.2004.053553
144. Gabel L, Macdonald HM, Nettlefold L, McKay HA. Bouts of vigorous physical activity and bone strength accrual during adolescence. Pediatr Exercise Sci. (2017) 29:465–75. doi: 10.1123/pes.2017-0043
145. Chaplais E, Naughton G, Greene D, Dutheil F, Pereira B, Thivel D, et al. Effects of interventions with a physical activity component on bone health in obese children and adolescents: a systematic review and meta-analysis. J Bone Mineral Metabol. (2018) 36:12–30. doi: 10.1007/s00774-017-0858-z
146. Cardadeiro G, Baptista F, Ornelas R, Janz KF, Sardinha LB. Sex specific association of physical activity on proximal femur BMD in 9 to 10 years-old children. PLoS ONE. (2012) 7:e50657. doi: 10.1371/journal.pone.0050657
147. Parfitt AM. The two faces of growth: benefits and risks to bone integrity. Osteoporosis Int. (1994) 4:382–98. doi: 10.1007/BF01622201
148. Seeman E. Clinical review 137: Sexual dimorphism in skeletal size, density, and strength. J Clin Endocrinol Metabol. (2001) 86:4576–84. doi: 10.1210/jcem.86.10.7960
149. Specker B, Thiex NW, Sudhagoni RG. Does exercise influence pediatric bone? A Systematic Review. Clin Orthopaed Related Res. (2015) 473:3658–72. doi: 10.1007/s11999-015-4467-7
150. Coetzee M, Haag M, Joubert AM, Kruger MC. Effects of arachidonic acid, docosahexaenoic acid and prostaglandin E2 on cell proliferation and morphology of MG-63 and MC3T3-E1 osteoblast-like cells. Prostagland Leukotri Essential Fatty Acids. (2007) 76:35–45. doi: 10.1016/j.plefa.2006.10.001
151. Casado-Díaz A, Santiago-Mora R, Dorado G, Quesada-Gómez JM. The omega-6 arachidonic fatty acid, but not the omega-3 fatty acids, inhibits osteoblastogenesis and induces adipogenesis of human mesenchymal stem cells: potential implication in osteoporosis. Osteoporosis Int. (2013) 24:1647–61. doi: 10.1007/s00198-012-2138-z
152. Watkins BA, Li Y, Lippman HE, Feng S. Modulatory effect of omega-3 polyunsaturated fatty acids on osteoblast function and bone metabolism. Prostagland Leukotri Essential Fatty Acids. (2003) 68:387–98. doi: 10.1016/S0952-3278(03)00063-2
153. Oh YC, Kang OH, Choi JG, Brice OO, Lee YS, Keum JH, et al. Anti-allergic effects of sinomenine by inhibition of prostaglandin D2 and leukotriene C4 in mouse bone marrow-derived mast cells. Immunopharmacology and Immunotoxicology. (2011) 33:266–70. doi: 10.3109/08923973.2010.499914
154. Drosatos-Tampakaki Z, Drosatos K, Siegelin Y, Gong S, Khan S, Van Dyke T, et al. Palmitic acid and DGAT1 deficiency enhance osteoclastogenesis, while oleic acid-induced triglyceride formation prevents it. J Bone Mineral Res. (2014) 29:1183–95. doi: 10.1002/jbmr.2150
155. Uchida R, Chiba H, Ishimi Y, Uehara M, Suzuki K, Kim H, et al. Combined effects of soy isoflavone and fish oil on ovariectomy-induced bone loss in mice. J Bone Mineral Metabol. (2011) 29:404–13. doi: 10.1007/s00774-010-0234-8
156. Azuma MM, Gomes-Filho JE, Ervolino E, Pipa CB, Cardoso C, De BM, et al. Omega 3 fatty acids reduce bone resorption while promoting bone generation in rat apical periodontitis. J Endodont. (2017) 43:970–6. doi: 10.1016/j.joen.2017.01.006
157. Rahman MM, Bhattacharya A, Fernandes G. Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid. J Cell Physiol. (2008) 214:201–9. doi: 10.1002/jcp.21188
158. Kim SP, Li Z, Zoch ML, Frey JL, Bowman CE, Kushwaha P, et al. Fatty acid oxidation by the osteoblast is required for normal bone acquisition in a sex- and diet-dependent manner. JCI Insight. (2017) 2:e92704. doi: 10.1172/jci.insight.92704
159. Yuan J, Akiyama M, Nakahama K, Sato T, Uematsu H, Morita I. The effects of polyunsaturated fatty acids and their metabolites on osteoclastogenesis in vitro. Prostagl Other Lipid Mediat. (2010) 92:85–90. doi: 10.1016/j.prostaglandins.2010.04.001
160. Garcia C1, Qiao M, Chen D, Kirchen M, Gallwitz W, Mundy GR, et al. Effects of synthetic peptido-leukotrienes on bone resorption in vitro. J Bone Miner Res. (1996) 11:521–9. doi: 10.1002/jbmr.5650110413
161. Kasonga AE, Deepak V, Kruger MC, Coetzee M. Arachidonic acid and docosahexaenoic acid suppress osteoclast formation and activity in human CD14+ monocytes, in vitro. PLoS ONE. (2015) 10:125145. doi: 10.1371/journal.pone.0125145
162. Heidemann M, Mølgaard C, Husby S, Schou AJ, Klakk H, Møller NC, et al. The intensity of physical activity influences bone mineral accrual in childhood: the childhood health, activity and motor performance school (the CHAMPS) study, Denmark. BMC Pediatr. (2013) 13:32. doi: 10.1186/1471-2431-13-32
163. Ivuškāns A, Mäestu J, Jürimäe T, Lätt E, Purge P, Saar M, et al. Sedentary time has a negative influence on bone mineral parameters in peripubertal boys: a 1-year prospective study. J Bone Mineral Metabol. (2015) 33:85–92. doi: 10.1007/s00774-013-0556-4
164. Vaitkeviciute D, Lätt E, Mäestu J, Jürimäe T, Saar M, Purge P, et al. Physical activity and bone mineral accrual in boys with different body mass parameters during puberty: a longitudinal study. PLoS ONE. (2014) 9:e107759. doi: 10.1371/journal.pone.0107759
165. Janicka A, Wren TAL, Sanchez MM, Dorey F, Kim PS, Mittelman SD, et al. Fat mass is not beneficial to bone in adolescents and young adults. J Clin Endocrinol Metabol. (2007) 92:143–7. doi: 10.1210/jc.2006-0794
166. Mcgartland CP, Robson PJ, Murray LJ, Cran GW, Savage MJ, Watkins DC, et al. Fruit and vegetable consumption and bone mineral density: the Northern Ireland Young Hearts Project. Am J Clin Nutr. (2004) 80:1019–23. doi: 10.1093/ajcn/80.4.1019
167. Bushinsky DA. Acid-base imbalance and the skeleton. Eur J Nutr. (2001) 40:238–44. doi: 10.1007/s394-001-8351-5
168. Rafferty K, Heaney RP. Nutrient effects on the calcium economy: emphasizing the potassium controversy. J Nutr. (2008) 138:166S−71S. doi: 10.1093/jn/138.1.166S
169. Wosje KS, Khoury PR, Claytor RP, Copeland KA, Hornung RW, Daniels SR, et al. Dietary patterns associated with fat and bone mass in young children. Am J Clin Nutr. (2010) 92:294–303. doi: 10.3945/ajcn.2009.28925
170. Seiquer I, Mesías M, Hoyos AM, Galdó G, Navarro MP. A Mediterranean dietary style improves calcium utilization in healthy male adolescents. J Am College Nutrition. (2008) 27:454–62. doi: 10.1080/07315724.2008.10719725
171. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a mediterranean diet and survival in a greek population. N Engl J Med. (2003) 348:2599–608. doi: 10.1056/NEJMoa025039
172. Prynne CJ, Mishra GD, O'Connell MA, Muniz G, Laskey MA, Yan L, et al. Fruit and vegetable intakes and bone mineral status: a cross sectional study in 5 age and sex cohorts. Am J Clin Nutr. (2006) 83:1420–8. doi: 10.1093/ajcn/83.6.1420
173. Grunwald T, Fadia S, Bernstein B, Naliborski M, Wu S, Luca F, et al. Vitamin D supplementation, the metabolic syndrome and oxidative stress in obese children. J Pediatr Endocrinol Metabol. (2017) 30:383–8. doi: 10.1515/jpem-2016-0211
174. Cheng L. The convergence of two epidemics: vitamin d deficiency in obese school-aged children. J Pediatr Nursing. (2018) 38:20–6. doi: 10.1016/j.pedn.2017.10.005
175. Zakharova I, Klimov L, Kuryaninova V, Nikitina I, Malyavskaya S, Dolbnya S, et al. Vitamin D insufficiency in overweight and obese children and adolescents. Front Endocrinol. (2019) 10:103. doi: 10.3389/fendo.2019.00103
176. Cauley JA, Danielson ME, Boudreau RM, Forrest KYZ, Zmuda JM, Pahor M, et al. Inflammatory markers and incident fracture risk in older men and women: the health aging and body composition study. J Bone Mineral Res. (2007) 22:1088–95. doi: 10.1359/jbmr.070409
177. Barbour KE, Boudreau R, Danielson ME, Youk AO, Wactawski-Wende J, Greep NC, et al. Inflammatory markers and the risk of hip fracture: the Women's Health Initiative. J Bone Mineral Res. (2012) 27:1167–76. doi: 10.1002/jbmr.1559
178. Ding C, Parameswaran V, Udayan R, Burgess J, Jones G. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. J Clin Endocrinol Metabol. (2008) 93:1952–8. doi: 10.1210/jc.2007-2325
179. Kelly OJ, Gilman JC, Kim Y, Ilich JZ. Long-chain polyunsaturated fatty acids may mutually benefit both obesity and osteoporosis. Nutrition Res. (2013) 33:521–33. doi: 10.1016/j.nutres.2013.04.012
180. Chen Y, Ho SC, Lam SS. Higher sea fish intake is associated with greater bone mass and lower osteoporosis risk in postmenopausal Chinese women. Osteoporosis Int. (2010) 21:939–46. doi: 10.1007/s00198-009-1029-4
181. Farina EK, Kiel DP, Roubenoff R, Schaefer EJ, Cupples LA, Tucker KL. Protective effects of fish intake and interactive effects of long-chain polyunsaturated fatty acid intakes on hip bone mineral density in older adults: the Framingham Osteoporosis Study. Am J Clin Nutrition. (2011) 93:1142–51. doi: 10.3945/ajcn.110.005926
182. Virtanen JK, Mozaffarian D, Willett WC, Feskanich D. Dietary intake of polyunsaturated fatty acids and risk of hip fracture in men and women. Osteoporosis Int. (2012) 23:2615–24. doi: 10.1007/s00198-012-1903-3
183. Calderon-Garcia J, Moran J, Roncero-Martin R, Rey-Sanchez P, Rodriguez-Velasco F, Pedrera-Zamorano J. Dietary habits, Nutrients and bone mass in spanish premenopausal women: the contribution of fish to better bone health. Nutrients. (2012) 5:10–22. doi: 10.3390/nu5010010
184. Saini RK, Keum Y-S. Omega-3 and omega-6 polyunsaturated fatty acids: dietary sources, metabolism, and significance. Rev Life Sci. (2018) 203:255–67. doi: 10.1016/j.lfs.2018.04.049
185. Kohli P, Levy BD. Resolvins and protectins: mediating solutions to inflammation. Br J Pharmacol. (2009) 158:960–71. doi: 10.1111/j.1476-5381.2009.00290.x
186. Harasymowicz NS, Dicks A, Wu C-L, Guilak F. Physiologic and pathologic effects of dietary free fatty acids on cells of the joint. Annals N Y Acad Sci. (2019) 1440:36–53. doi: 10.1111/nyas.13999
187. Boeyens JCA, Deepak V, Chua WH, Kruger MC, Joubert AM, Coetzee M. Effects of ω3- and ω6-polyunsaturated fatty acids on RANKL-induced osteoclast differentiation of RAW264.7 cells: a comparative in vitro study. Nutrients. (2014) 6:2584–601. doi: 10.3390/nu6072584
188. Nicolin V, De Tommasi N, Nori SL, Costantinides F, Berton F, Di Lenarda R. Modulatory effects of plant polyphenols on bone remodeling: a prospective view from the bench to bedside. Front Endocrinol. (2019) 10:494. doi: 10.3389/fendo.2019.00494
189. Austermann K, Baecker N, Stehle P, Heer M. Putative effects of nutritive polyphenols on bone metabolism in vivo-evidence from human studies. Nutrients. (2019) 11:871. doi: 10.3390/nu11040871
190. Melguizo-Rodríguez L, Manzano-Moreno FJ, Illescas-Montes R, Ramos-Torrecillas J, Luna-Bertos E, De Ruiz C. Bone protective effect of extra-virgin olive oil phenolic compounds by modulating osteoblast gene expression. Nutrients. (2019) 11:1722. doi: 10.3390/nu11081722
191. García-Martínez O, De Luna-Bertos E, Ramos-Torrecillas J, Ruiz C, Milia E, Lorenzo ML, et al. Phenolic compounds in extra virgin olive oil stimulate human osteoblastic cell proliferation. PLoS ONE. (2016) 11:e0150045. doi: 10.1371/journal.pone.0150045
192. Anter J, Quesada-Gómez JM, Dorado G, Casado-Díaz A. Effect of hydroxytyrosol on human mesenchymal stromal/stem cell differentiation into adipocytes and osteoblasts. Arch Med Res. (2016) 47:162–71. doi: 10.1016/j.arcmed.2016.06.006
193. Goto T, Hagiwara K, Shirai N, Yoshida K, Hagiwara H. Apigenin inhibits osteoblastogenesis and osteoclastogenesis and prevents bone loss in ovariectomized mice. Cytotechnology. (2015) 67:357–65. doi: 10.1007/s10616-014-9694-3
194. Shen C-L, Chyu M-C, Cao JJ, Yeh JK. Green tea polyphenols improve bone microarchitecture in high-fat-diet-induced obese female rats through suppressing bone formation and erosion. J Med Food. (2013) 16:421–7. doi: 10.1089/jmf.2012.0199
195. Shen C-L, Han J, Wang S, Chung E, Chyu M-C, Cao JJ. Green tea supplementation benefits body composition and improves bone properties in obese female rats fed with high-fat diet and caloric restricted diet. Nutrition Res. (2015) 35:1095–105. doi: 10.1016/j.nutres.2015.09.014
196. Vester H, Holzer N, Neumaier M, Lilianna S, Nüssler AK, Seeliger C. Green tea extract (GTE) improves differentiation in human osteoblasts during oxidative stress. J Inflamm. (2014) 11:15. doi: 10.1186/1476-9255-11-15
Keywords: bone, child, inflammation, lifestyle, obesity, physical activity, polyphenols, polyunsaturated fatty acids
Citation: Fintini D, Cianfarani S, Cofini M, Andreoletti A, Ubertini GM, Cappa M and Manco M (2020) The Bones of Children With Obesity. Front. Endocrinol. 11:200. doi: 10.3389/fendo.2020.00200
Received: 06 December 2019; Accepted: 20 March 2020;
Published: 24 April 2020.
Edited by:
Amélie E. Coudert, Université Paris Diderot, FranceReviewed by:
Maria Felicia Faienza, University of Bari Aldo Moro, ItalyConnie M. Weaver, Purdue University, United States
Copyright © 2020 Fintini, Cianfarani, Cofini, Andreoletti, Ubertini, Cappa and Manco. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Danilo Fintini, ZGFuaWxvLmZpbnRpbmkmI3gwMDA0MDtvcGJnLm5ldA==; Melania Manco, bWVsYW5pYS5tYW5jbyYjeDAwMDQwO29wYmcubmV0
†These authors have contributed equally to this work